(S (NP (PRP We)) (VP (VBD introduced) (NP (DT a) (NN methodology)) (S (VP (TO to) (ADVP (RB efficiently)) (VP (VB exploit) (NP (NML (JJ natural) (HYPH -) (NN language)) (NML (VBN expressed) (JJ biomedical) (NN knowledge))) (PP (IN for) (S (VP (VBG repurposing) (NP (VBG existing) (NNS drugs)) (PP (IN towards) (NP (NP (NNS diseases)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (PRP they)) (VP (VBD were) (RB not) (ADVP (RB initially)) (VP (VBN intended)))))))))))))) (. .))
(S (S (S (VP (VBG Leveraging) (PP (IN on) (NP (NP (NNS developments)) (PP (IN in) (NP (NP (NNP Computational) (NNP Linguistics)) (CC and) (NP (NNP Graph) (NNP Theory)))))))) (, ,) (NP (DT a) (NN methodology)) (VP (VBZ is) (VP (VBN defined) (S (VP (TO to) (VP (VB build) (NP (NP (DT a) (NN graph) (NN representation)) (PP (IN of) (NP (NP (NN knowledge)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB automatically)) (VP (VBN analysed) (S (VP (TO to) (VP (VB discover) (NP (NP (JJ hidden) (NNS relations)) (PP (IN between) (NP (NP (DT any) (NN drug)) (CC and) (NP (DT any) (NN disease))))))))))))))))))))) (: :) (S (NP (DT these) (NNS relations)) (VP (VBP are) (NP (NP (NP (JJ specific) (NNS paths)) (PP (IN among) (NP (NP (DT the) (JJ biomedical) (NNS entities)) (PP (IN of) (NP (DT the) (NN graph)))))) (, ,) (VP (VBG representing) (NP (NP (JJ possible) (NNS Modes)) (PP (IN of) (NP (NN Action)))) (PP (IN for) (NP (DT any) (VBN given) (JJ pharmacological) (NN compound))))))) (. .))
(S (NP (DT These) (NNS paths)) (VP (VBP are) (VP (VBN ranked) (PP (VBG according) (PP (IN to) (NP (PRP$ their) (NN relevance)))) (, ,) (S (VP (VBG exploiting) (NP (NP (DT a) (NN measure)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ stochastic) (NN process)) (VP (VBN defined) (PP (IN on) (NP (DT the) (NN graph)))))))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (, ,) (S (VP (VBG providing) (NP (NML (JJ real) (HYPH -) (NN world)) (NNS examples)))) (, ,) (SBAR (WHADVP (WRB how)) (S (NP (DT the) (NN method)) (ADVP (RB successfully)) (VP (VP (VBZ retrieves) (VP (VBN known) (NP (NP (JJ pathophysiological) (NNP Mode)) (PP (IN of) (NP (NNS Actions)))))) (CC and) (VP (VBZ finds) (NP (JJ new) (NNS ones)) (PP (IN by) (S (ADVP (RB meaningfully)) (VP (VBG selecting) (CC and) (VBG aggregating) (NP (NP (NNS contributions)) (PP (IN from) (NP (VBN known) (JJ bio-molecular) (NNS interactions)))))))))))) (. .))
(S (NP (NP (NNS Applications)) (PP (IN of) (NP (DT this) (NN methodology)))) (VP (VP (VBP are) (VP (VBN presented))) (, ,) (CC and) (VP (VB prove) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT the) (NN method)))) (PP (IN for) (S (VP (VBG selecting) (NP (NNS drugs)) (PP (IN as) (NP (NP (NN treatment) (NNS options)) (PP (IN for) (NP (JJ rare) (NNS diseases)))))))))) (. .))
